NM_001320298.2:c.-251G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001320298.2(CBS):c.-251G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.88 ( 51950 hom., cov: 20)
Exomes 𝑓: 0.85 ( 20 hom. )
Failed GnomAD Quality Control
Consequence
CBS
NM_001320298.2 5_prime_UTR
NM_001320298.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.00
Publications
17 publications found
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
CBS Gene-Disease associations (from GenCC):
- classic homocystinuriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 21-43076866-C-G is Benign according to our data. Variant chr21-43076866-C-G is described in ClinVar as Benign. ClinVar VariationId is 1168575.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CBS | NM_001320298.2 | c.-251G>C | 5_prime_UTR_variant | Exon 1 of 18 | NP_001307227.1 | |||
| CBS | XM_047441024.1 | c.-251G>C | 5_prime_UTR_variant | Exon 1 of 19 | XP_047296980.1 | |||
| CBS | XM_047441025.1 | c.-686G>C | 5_prime_UTR_variant | Exon 1 of 20 | XP_047296981.1 | |||
| CBS | XM_047441030.1 | c.-251G>C | 5_prime_UTR_variant | Exon 1 of 19 | XP_047296986.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CBS | ENST00000441030.5 | c.-211G>C | 5_prime_UTR_variant | Exon 1 of 6 | 5 | ENSP00000388235.1 |
Frequencies
GnomAD3 genomes AF: 0.879 AC: 113408AN: 129004Hom.: 51920 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
113408
AN:
129004
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.852 AC: 46AN: 54Hom.: 20 Cov.: 0 AF XY: 0.857 AC XY: 36AN XY: 42 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
46
AN:
54
Hom.:
Cov.:
0
AF XY:
AC XY:
36
AN XY:
42
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
4
AN:
6
South Asian (SAS)
AF:
AC:
1
AN:
2
European-Finnish (FIN)
AF:
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
38
AN:
42
Other (OTH)
AF:
AC:
2
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.583
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.879 AC: 113479AN: 129092Hom.: 51950 Cov.: 20 AF XY: 0.874 AC XY: 54201AN XY: 62046 show subpopulations
GnomAD4 genome
AF:
AC:
113479
AN:
129092
Hom.:
Cov.:
20
AF XY:
AC XY:
54201
AN XY:
62046
show subpopulations
African (AFR)
AF:
AC:
33146
AN:
39132
American (AMR)
AF:
AC:
9197
AN:
12840
Ashkenazi Jewish (ASJ)
AF:
AC:
2686
AN:
3002
East Asian (EAS)
AF:
AC:
3691
AN:
4188
South Asian (SAS)
AF:
AC:
3305
AN:
3786
European-Finnish (FIN)
AF:
AC:
6312
AN:
6966
Middle Eastern (MID)
AF:
AC:
233
AN:
264
European-Non Finnish (NFE)
AF:
AC:
52793
AN:
56510
Other (OTH)
AF:
AC:
1577
AN:
1784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
452
904
1355
1807
2259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
2313
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.